Thiamylal Sodium

硫戊比妥钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameThiamylal Sodium
Drug Alias Name苏里塔耳钠IsozolCitosol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesParkedale Pharmaceuticals, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnesthesia

Other Information

ATC CodeN/A